Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum uric acid and the incidence of CKD and hypertension
Satoru Kuriyama, Yukio Maruyama, Shinichiro Nishio, et al.
Clinical and Experimental Nephrology (2015) Vol. 19, Iss. 6, pp. 1127-1134
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population
Carlo Garofalo, Silvio Borrelli, Roberto Minutolo, et al.
Kidney International (2017) Vol. 91, Iss. 5, pp. 1224-1235
Open Access | Times Cited: 295
Management of Gout and Hyperuricemia in CKD
Ana Beatriz Vargas‐Santos, Tuhina Neogi
American Journal of Kidney Diseases (2017) Vol. 70, Iss. 3, pp. 422-439
Open Access | Times Cited: 179
Pathophysiology of hyperuricemia and its clinical significance – a narrative review
Marta Skoczyńska, Małgorzata Chowaniec, Maciej Szymczak, et al.
Reumatologia/Rheumatology (2020) Vol. 58, Iss. 5, pp. 312-323
Open Access | Times Cited: 78
Association of Uric Acid–Lowering Therapy With Incident Chronic Kidney Disease
Waleed Hassan, Prabin Shrestha, Keiichi Sumida, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2215878-e2215878
Open Access | Times Cited: 46
Time to target uric acid to retard CKD progression
Takanori Kumagai, Tatsuru Ota, Yoshifuru Tamura, et al.
Clinical and Experimental Nephrology (2016) Vol. 21, Iss. 2, pp. 182-192
Closed Access | Times Cited: 79
Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease—A Propensity Score Analysis
Shunya Uchida, Wenxiu Chang, Tatsuru Ota, et al.
PLoS ONE (2015) Vol. 10, Iss. 12, pp. e0145506-e0145506
Open Access | Times Cited: 52
Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study
Keita Kamei, Tsuneo Konta, Atsushi Hirayama, et al.
Clinical and Experimental Nephrology (2016) Vol. 21, Iss. 3, pp. 497-503
Closed Access | Times Cited: 49
The association between hyperuricemia and atrial fibrillation recurrence after catheter ablation
Hirotsuna Oseto, Seigo Yamashita, Michifumi Tokuda, et al.
Journal of Arrhythmia (2024) Vol. 40, Iss. 3, pp. 520-526
Open Access | Times Cited: 4
The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Shengjie Li, Mingxi Shao, Binghua Tang, et al.
Oncotarget (2016) Vol. 8, Iss. 2, pp. 2816-2824
Open Access | Times Cited: 37
The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3–5
Xuemei Liu, Huifang Wang, Ruixia Ma, et al.
Clinical and Experimental Nephrology (2018) Vol. 23, Iss. 3, pp. 362-370
Closed Access | Times Cited: 32
Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia
Satoru Kuriyama
Clinical and Experimental Nephrology (2019) Vol. 24, Iss. S1, pp. 1-5
Open Access | Times Cited: 27
Close linkage between serum uric acid and cardiac dysfunction in patients with ischemic heart disease according to covariance structure analysis
Yoshiro Tanaka, Tomohisa Nagoshi, Makoto Kawai, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 25
Gender interaction of uric acid in the development of hypertension
Shinichiro Nishio, Yukio Maruyama, Naoki Sugano, et al.
Clinical and Experimental Hypertension (2017) Vol. 40, Iss. 5, pp. 446-451
Closed Access | Times Cited: 24
The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study
Meiyu Ye, Kang Hu, Juan Jin, et al.
BMC Nephrology (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 22
Disparity of serum uric acid threshold for CKD among hypertensive and non-hypertensive individuals
Bowen Zhu, Fang Li, Weidong Zhang, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 2
Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males
Zhiwei Zhou, Kai Song, Jing Qiu, et al.
PLoS ONE (2016) Vol. 11, Iss. 11, pp. e0166072-e0166072
Open Access | Times Cited: 18
High Serum Uric Acid is Highly Associated with a Reduced Left Ventricular Ejection Fraction Rather than Increased Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Diseases
Yoshitsugu Oki, Makoto Kawai, Kosuke Minai, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, et al.
Clinical and Experimental Nephrology (2019) Vol. 24, Iss. S1, pp. 53-61
Open Access | Times Cited: 17
Association between serum uric acid and chronic kidney disease in patients with hypertension: A multicenter nationwide cross‐sectional study
Wisit Kaewput, Charat Thongprayoon, Ram Rangsin, et al.
Journal of Evidence-Based Medicine (2019) Vol. 12, Iss. 4, pp. 235-242
Closed Access | Times Cited: 16
Prevalence and Associated Risk Factors of Hypertension in Adults with Disabilities: A Cross-Sectional Study in Shanghai, China
Hengjing Wu, Jing Wu, Ziyan Zhang, et al.
Clinical Epidemiology (2021) Vol. Volume 13, pp. 769-777
Open Access | Times Cited: 13
Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study
Naoki Sugano, Yukio Maruyama, Satoshi Kidoguchi, et al.
PLoS ONE (2019) Vol. 14, Iss. 6, pp. e0217859-e0217859
Open Access | Times Cited: 14
Decline in serum uric acid predicts higher risk for mortality in peritoneal dialysis patients—a propensity score analysis
Wenxiu Chang, Shunya Uchida, Ping‐Ping Qi, et al.
Journal of Nephrology (2019) Vol. 33, Iss. 3, pp. 591-599
Closed Access | Times Cited: 13
The effect of baseline serum uric acid on chronic kidney disease in normotensive, normoglycemic, and non-obese individuals: A health checkup cohort study
Young-Bin Son, Jihyun Yang, Myung-Gyu Kim, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0244106-e0244106
Open Access | Times Cited: 10
The time-averaged serum uric acid can better predict the prognosis of IgA nephropathy
Chenchen Qi, Xudong Liu, Jing Mao, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024), pp. 103800-103800
Open Access | Times Cited: 1
Uric acid-lowering effect of dotinurad, a novel selective urate reabsorption inhibitor, in hypertensive patients with gout or asymptomatic hyperuricemia: a pooled analysis of individual participant data in phase II and III trials
Toshinari Takahashi, Takanobu Beppu, Yuji Hidaka, et al.
Clinical and Experimental Hypertension (2021) Vol. 43, Iss. 8, pp. 730-741
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top